Carl v. Johnson & Johnson
(N.J., filed October 5, 2020): Urging the New Jersey Supreme Court to review a lower court’s incorrect application of the state’s expert evidence standard. Arguing that the Court needs to overturn the decision to reinforce the message of its opinion in In re Accutane. The opinion, if not reversed, will leave trial courts with great uncertainty as to the gatekeeping role in New Jersey’s many drug, tort and product lawsuits.
Latest News
View all news
ATRA Urges DeSantis Veto of H.B. 6017 to Protect Florida’s Civil Justice Gains
Bill Would Expand Litigation, Risk Returning State to ‘Judicial Hellhole’
ATRA Statement on Colorado HB 1291: Lawmakers Should Reject Bill That Would Fuel Lawsuit Abuse
State Risks ‘Lawsuit Inferno’ Status
Gov. Kemp Signs Major Tort Reform Bills in ‘Judicial Hellhole’ Georgia
ATRA Lauds New Laws Addressing Phantom Damages, Litigation Financing and More
Groups Urge Congressional Scrutiny of D.C. Attorney General’s Use of Private Attorneys
Concerns Mount Over Outside Counsel Contracts and Litigation Agendas
America’s $367 Billion Lawsuit Epidemic
The Hidden Tax Crushing Families and Businesses
$745 Million Verdict in Coastal Litigation Exemplifies Louisiana’s ‘Judicial Hellhole®’ Status
Excessive Litigation Costs Residents $1,011 Annually and Jeopardizes 40,000 Jobs Each Year